Armistice Capital, LLC Dermata Therapeutics Inc Wt Ex Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
A detailed history of Armistice Capital, LLC transactions in Dermata Therapeutics Inc Wt Ex stock. As of the latest transaction made, Armistice Capital, LLC holds 1,354 shares of DRMAW stock, worth $40. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,354Holding current value
$40% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding DRMAW
# of Institutions
7Shares Held
205KCall Options Held
0Put Options Held
0-
Empery Asset Management, LP New York, NY175KShares$5,2500.1% of portfolio
-
Two Sigma Securities, LLC New York, NY12.9KShares$3850.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY12KShares$3600.0% of portfolio
-
Ubs Group Ag4.14KShares$1240.0% of portfolio
-
Bank Of America Corp Charlotte, NC100Shares$30.0% of portfolio
About DERMATA THERAPEUTICS INC WT EX
- Ticker DRMAW
- Sector Healthcare
- Industry Biotechnology